English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51810588    ???header.onlineuser??? :  974
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"whang peng j"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 96-145 of 215  (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

Institution Date Title Author
高雄醫學大學 2011 A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.  趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. 
國家衛生研究院 2010-06 Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma Shiah, H;Chen, C;Lin, Y;Su, W;Winkler, R;Chang, J;Lin, P;Whang-Peng, J;Chen, L
國家衛生研究院 2009-12 Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent Chen, LT;Shiah, HS;Chao, Y;Chang, JY;Cheng, LT;Whang-Peng, J
國家衛生研究院 2009-11 Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer Ch'ang, HJ;Huang, CL;Wang, HP;Shiah, HS;Chang, MC;Jan, CM;Chen, JS;Tien, YW;Hwang, TL;Lin, JT;Cheng, AL;Whang-Peng, J;Chen, LT
國立臺灣大學 2009-11 Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. Cancer Chemother Pharmacol. Chang, HJ; Huang, CL; Wang, HP; Shiah, HS; Chang, MC; Jan, CM; Chen, JS; Tien, YW; Hwang, TL; Lin, JT; Cheng, AL; Whang-Peng, J; Chen, LT.
國家衛生研究院 2009-05-20 Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan Chen, Y;Tsai, C;Shih, J;Perng, R;Whang-Peng, J
國家衛生研究院 2008-08 A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly Chen, YM;Perng, RP;Shih, JF;Whang-Peng, J
國家衛生研究院 2008-07 Diagnostic and therapeutic evaluation of In-111-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model Chow, TH; Lin, YY; Hwang, JJ; Wang, HE; Tseng, YL; Pang, VF; Wang, SJ; Whang-Peng, J; Ting, G
國家衛生研究院 2008-06 Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma Yuan, JN; Chao, Y; Lee, WP; Li, CP; Lee, RC; Chang, FY; Yen, SH; Lee, SD; Whang-Peng, J
國家衛生研究院 2008-01-08 Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial Wu, CW; Chiou, JM; Ko, FS; Lo, SS; Chen, JH; Lui, WY; Whang-Peng, J
國家衛生研究院 2008-01 Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy Chou, KT; Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院 2007-09 Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: Different cytogenetic changes are correlated with genders and smoking habits Yen, CC; Liang, SC; Jong, YJ; Chen, YJ; Lin, CH; Chen, YM; Wu, YC; Su, WC; Huang, CYF; Tseng, SW; Whang-Peng, J
國家衛生研究院 2007-06-01 Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme Su, LJ; Chang, CW; Wu, YC; Chen, KC; Lin, CJ; Liang, SC; Lin, CH; Whang-Peng, J; Hsu, SL; Chen, CH; Huang, CYF
國家衛生研究院 2007-06 A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國家衛生研究院 2007-05 Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy Chen, YM;Liu, JM;Chou, TY;Perng, RP;Tsai, CM;Whang-Peng, J
國家衛生研究院 2007-03 Effect of age on pulmonary metastases and immunotherapy in young and middle-aged mice Chen, YM;Wang, PS;Liu, JM;Hsieh, YL;Tsai, CM;Perng, RP;Whang-Peng, J
國家衛生研究院 2007-02-01 Monitoring and quantitative assessment of tumor burden using in vivo bioluminescence imaging Chen, CC; Hwang, JJ; Ting, G; Tseng, YL; Wang, SJ; Whang-Peng, J
國家衛生研究院 2007-02 Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy Chen, CK; Hsueh, C; Lai, JY; Hung, IJ; Whang-Peng, J; Wang, WP; Lai, HY; Chen, JR
國家衛生研究院 2006-12-20 Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts Lee, WC; Hwang, JJ; Tseng, YL; Wang, HE; Chang, YF; Lu, YC; Ting, G; Whang-Peng, J; Wang, SJ
國家衛生研究院 2006-12-20 Internal radiotherapy and dosimetric study for In-111/Lu-177-pegylated liposomes conjugates in tumor-bearing mice Wang, HE; Yu, HM; Lu, YC; Heish, NN; Tseng, YL; Huang, KL; Chuang, KT; Chen, CH; Hwang, JJ; Lin, WJ; Wang, SJ; Ting, G; Whang-Peng, J; Deng, WP
國家衛生研究院 2006-11 Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW
國家衛生研究院 2006-10-01 Identification of alpha-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes Chang, GC; Liu, KJ; Hsieh, CL; Hu, TS; Charoenfuprasert, S; Liu, HK; Luh, KT; Hsu, LH; Wu, CW; Ting, CC; Chen, CY; Chen, KC; Yang, TY; Chou, TY; Wang, WH; Whang-Peng, J; Shih, NY
國家衛生研究院 2006-07 Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國家衛生研究院 2006-06 A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院 2006-05 Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT
國家衛生研究院 2006-04 Nodal dissection for patients with gastric cancer: a randomised controlled trial Wu, CW; Hsiung, CA; Lo, SS; Hsieh, MC; Chen, JH; Li, AFY; Lui, WY; Whang-Peng, J
國家衛生研究院 2006-04 A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院 2006-04 Erlotinib completely reverses topotecan-resistance in multidrug resistant cancer cells overexpressing breast cancer resistant protein 1 Yang, CH;Yang, CS;Huang, CJ;Cheng, AL;Whang-Peng, J;Yang, PC
國家衛生研究院 2006-04 Topoisomerase 2 alpha plays a pivotal role in the tumor biology of advanced thymic neoplasia Liu, JM;Hwang, BS;Wang, LS;Huang, MH;Yen, SH;Li, A;Tiu, CM;Whang-Peng, J
國家衛生研究院 2006-03 Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT
國家衛生研究院 2006-02 A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院 2006-01 Complications following D3 gastrectomy: Post hoc analysis of a randomized trial Wu, CW; Chang, IS; Lo, SS; Hsieh, MC; Chen, JH; Lui, WY; Whang-Peng, J
國家衛生研究院 2005-12 Pulmonary embolism after transcatheter arterial chemoembolization Shiah, HS; Liu, TW; Chen, LT; Chang, JY; Liu, JM; Chuang, TR; Lee, WS; Whang-Peng, J
國家衛生研究院 2005-09-21 Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma Chen, LT; Lin, JT; Tai, JJ; Chen, GH; Yeh, HZ; Yang, SS; Wang, HP; Kuo, SH; Sheu, BS; Jan, CM; Wang, WM; Wang, TE; Wu, CW; Chen, CL; Su, IJ; Whang-Peng, J; Cheng, AL
國家衛生研究院 2005-09-14 Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients Su, WP;Wen, CC;Hsiung, CA;Su, IJ;Cheng, AL;Chang, MC;Tsao, CJ;Kao, WY;Uen, WC;Hsu, CH;Lu, YS;Tien, HF;Chao, TY;Chen, LT;Whang-Peng, J;Chen, PJ
國家衛生研究院 2005-09 Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin Chan, CH; Liu, TW; Chen, LT; Chang, JY; Whang-Peng, J
國家衛生研究院 2005-08-01 Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein Yang, CH; Huang, CJ; Yang, CS; Chu, YC; Cheng, AL; Whang-Peng, J; Yang, PC
國家衛生研究院 2005-08-01 alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma Chen, LT; Liu, TW; Chao, Y; Shiah, HS; Chang, JY; Juang, SH; Chen, SC; Chuang, TR; Chin, YH; Whang-Peng, J
中國醫藥大學 2005-08 α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma (Chen. L.-T.*)*; (Liu, T.-W.); (Chao, Y); (Shiah, H.-S); (Chang, J.-Y.,); 莊聲宏(Shin-Hun Juang); (Chen, S.-C.); (Chuang, T.-R); (Chin, Y.-H.); (Whang-Peng, J.)
國家衛生研究院 2005-07 erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+in immunohistochemical analysis Lan, C; Liu, JM; Liu, TW; Hsu, DH; Liang, SC; Chen, JR; Whang-Peng, J
國家衛生研究院 2005-07 Chemotherapy for non-small cell lung cancer in elderly patients Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國立臺灣大學 2005-07 Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment. Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Kun-Huei, Yeh; Yu, YC; Whang-Peng, J; Yang, PC.
國家衛生研究院 2005-06 A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy Chen, YM;Perng, RP;Tsai, CM;Whang-Peng, J
國家衛生研究院 2005-05-20 Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma Chan, ATC; Hsu, MM; Goh, BC; Hui, EP; Liu, TW; Millward, MJ; Hong, RL; Whang-Peng, J; Ma, BBY; To, KF; Mueser, M; Amellal, N; Lin, X; Chang, AY
國家衛生研究院 2005-03 A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國家衛生研究院 2005-03 Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries Wu, CW;Hsiung, CA;Lo, SS;Hsieh, MC;Chen, JH;Li, AF;Lui, WY;Whang-Peng, J
國家衛生研究院 2005-02-15 A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma Chang, GC; Lan, HC; Juang, SH; Wu, YC; Lee, HC; Hung, YM; Yang, HY; Whang-Peng, J; Liu, KJ
中國醫藥大學 2005-02 A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma. (Chang, G.-C.); (Lan, H.-C); 莊聲宏(Shin-Hun Juang); (Wu, Y.-C.); (Lee, H.-C.); (Hung, Y.-M); (Yang, H.-Y.); (Whang-Peng, J); (Liu, K.-J*)*
國家衛生研究院 2005 Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Yeh, KH; Yu, YC; Whang-Peng, J; Yang, PC
高雄醫學大學 2005 Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.  陳立宗;林肇堂;許博翔;詹昌明;王文明;王蒼恩;鄭安理 ; Chen LT;Lin JT;Tai JJ;Chen GH;Yeh HZ;Yang SS;Wang HP;Kuo SH;Sheu BS;Jan CM;Wang WM;Wang TE;Wu CW;Chen CL;Su IJ;Whang-Peng J;Cheng AL 

Showing items 96-145 of 215  (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page